Background
Methods
Study area and national health system
Data sources
The 2014 SARA survey
Health outcome: malaria-related mortality among under-5-year-old
Statistical analysis
Results
Health facility characteristics and malaria mortality
Characteristics | Medical centres (n = 112) n (%) | Peripheral health centres (n = 546) n (%) |
---|---|---|
Location | ||
Urban | 90 (80.4) | 83 (15.2) |
Rural | 22 (19.6) | 463 (84.8) |
Administrative management | ||
Public | 86 (76.8) | 510 (93.4) |
Private | 26 (23.2) | 36 (6.6) |
Regions | ||
Boucle du Mouhoun | 9 (8.0) | 65 (11.9) |
Cascades | 4 (3.6) | 25 (4.6) |
Centre | 27 (24.1) | 54 (9.9) |
Centre-Est | 10 (8.9) | 38 (7.0) |
Centre-Nord | 6 (5.4) | 41 (7.5) |
Centre-Ouest | 11 (9.8) | 53 (9.7) |
Centre-Sud | 4 (3.6) | 30 (5.6) |
Est | 9 (8.0) | 40 (7.3) |
Hauts Bassins | 9 (8.0) | 55 (10.1) |
Nord | 8 (7.1) | 53 (9.7) |
Plateau Central | 4 (3.6) | 38 (7.0) |
Sahel | 4 (3.6) | 27 (5.0) |
Sud-Ouest | 7 (6.4) | 27 (5.0) |
Malaria | ||
Number of deaths (a) | 1860 | 347 |
Number of consultations (b) | 53,768 | 48,524 |
Mortality rate = a/b | 3.5% | 0.7% |
Domains and tracer items readiness’ indicators
Domain/tracer items | Medical centres (n = 112) | Peripheral health centres (n = 546) | ||
---|---|---|---|---|
Availability (%) | Posterior inclusion probability2 (%) | Availability (%) | Posterior inclusion probability (%) | |
General service | ||||
Basic amenities1 | 39 (34.8) | 6 (1.1) | ||
Power (electric or solar device) | 86 (76.8) | 8.5 | 362 (66.3) | 21.4 |
Improved water source inside or within the ground of the facility | 110 (98.2) | −3 | 476 (87.2) | 60.9 |
Room with auditory and visual privacy for patient consultations | 81 (72.3) | 100 | 284 (52.0) | 39.2 |
Access to adequate sanitation facilities for clients | 109 (97.3) | – | 519 (95.1) | – |
Communication equipment (phone or SW radio) | 111 (99.1) | – | 535 (98.0) | – |
Facility has access to computer with E-mail/Internet access | 56 (50.0) | 6.9 | 10 (1.8) | – |
Emergency transportation | 106 (94.6) | 61.7 | 515 (94.3) | 88.0 |
Basic equipment | 72 (64.2) | 264 (48.4) | ||
Adult scale | 108 (96.4) | – | 527 (96.5) | – |
Child scale | 82 (73.2) | 13.2 | 428 (78.4) | 15.1 |
Thermometer | 112 (100) | – | 544 (99.6) | – |
Stethoscope | 112 (100) | – | 540 (98.9) | – |
Blood pressure apparatus | 109 (97.3) | – | 533 (97.6) | – |
Light source | 92 (82.1) | 100 | 349 (63.9) | 16.2 |
Standard precautions for infection prevention | 52 (46.4) | 223 (40.8) | ||
Safe final disposal of sharp materials | 85 (75.9) | 84.7 | 422 (77.3) | 28.2 |
Safe final disposal of infectious wastes | 82 (73.2) | 62.9 | 336 (61.5) | 18.2 |
Appropriate storage of sharp waste | 110 (98.2) | – | 535 (98.0) | – |
Appropriate storage of infectious waste | 103 (92.0) | 85.3 | 494 (90.5) | 50.8 |
Disinfectant | 111 (99.1) | – | 544 (99.6) | – |
Single use (standard disposable or auto-disable syringes) | 111 (99.1) | – | 543 (99.5) | – |
Soap and running water or alcohol based hand rub | 105 (93.8) | 33.6 | 518 (94.9) | 99.2 |
Latex gloves | 100 (89.9) | 56.1 | 499 (91.4) | 99.3 |
Guidelines for standard precautions | 98 (87.5) | 98.3 | 469 (85.9) | 21.2 |
Diagnostic capacity | 37 (33.0) | 3 (0.6) | ||
Haemoglobin | 72 (64.3) | 100 | 9 (1.7) | – |
Blood glucose | 50 (44.6) | 48.2 | 6 (1.1) | – |
Malaria diagnostic capacity | 101 (90.2) | 17.5 | 467 (85.5) | 21.3 |
Urine dipstick-protein | 103 (92.0) | 49.0 | 501 (91.8) | 50.1 |
Urine dipstick-glucose | 104 (92.9) | 80.6 | 491 (89.9) | 31.4 |
HIV diagnostic capacity | 106 (94.6) | 32.9 | 512 (93.8) | 39.8 |
Urine test for pregnancy | 96 (85.7) | 26.0 | 412 (75.5) | 42.3 |
Essential medicines | 2 (0.1) | 0 (0) | ||
Amoxicillin tablet | 101 (90.2) | 40.6 | 523 (95.8) | – |
Ampicillin for inject | 104 (92.9) | 21.7 | 519 (95.1) | – |
Gentamicin injectable | 101 (90.2) | 77.7 | 472 (86.5) | 30.3 |
Oxytocin injectable | 98 (87.5) | 100 | 502 (91.9) | 77.8 |
Amoxicillin dispersible | 94 (83.9) | 10.6 | 475 (87.0) | 20.1 |
Oral rehydration solution (ORS) | 95 (84.8) | 16.8 | 476 (87.2) | 20.3 |
Zinc | 77 (68.8) | 100 | 418 (76.6) | 14.9 |
Aspirin | 94 (83.9) | 100 | 377 (69.1) | 19.6 |
Magnesium sulfate | 78 (69.6) | 100 | 121 (22.2) | 20.9 |
Amlodipine | 25 (22.3) | 100 | 12 (2.2) | – |
Enalapril | 20 (17.9) | 26.1 | 6 (1.1) | – |
Insulin injectable | 8 (7.1) | 35.9 | 5 (0.9) | – |
Betablockers | 20 (17.9) | 100 | 8 (1.5) | – |
Beclomethasone inhaler | 14 (12.5) | 100 | 9 (1.7) | – |
Ceftriaxone injection | 103 (92.0) | 93.8 | 492 (90.1) | 58.4 |
Thiazidic | 25 (22.3) | 14.2 | 41 (7.5) | 50.6 |
Glibenclamide tablet | 39 (34.8) | 100 | 10 (1.8) | – |
Metformin | 41 (36.6) | 22.9 | 9 (1.7) | – |
Omeprazole | 65 (58.0) | 10.1 | 110 (20.2) | 20.2 |
Salbutamol inhaler | 86 (76.8) | 63.3 | 288 (52.8) | 24.9 |
Carbamazepine | 28 (25.0) | 69.9 | 0 (0.0) | – |
Haloperidol | 27 (24.1) | 96.6 | 0 (0.0) | – |
Simvastatin | 4 (3.6) | – | ||
Fluoxetin | 3 (2.7) | – | – | |
Malaria-specific service | ||||
Staff and guidelines | 41 (45.5) | 313 (57.7) | ||
Guidelines for diagnosis and treatment of malaria | 105 (93.8) | 22.4 | 536 (98.2) | – |
Guidelines for intermittent preventive treatment | 75 (67.0) | 13.0 | 481 (88.1) | 31.1 |
Staff trained in malaria diagnosis and treatment | 79 (70.5) | 97.5 | 453 (83.0) | 40.9 |
Staff trained in intermittent preventive treatment | 74 (66.1) | 100 | 370 (67.8) | 58.9 |
Diagnostics | 101 (90.2) | 467 (85.5) | ||
Malaria diagnostic capacity (rapid diagnostic test/thin blood film) | 101 (90.2) | 17.5 | 467 (85.5) | 21.3 |
Medicines and commodities | 21 (18.8) | 172 (31.5) | ||
First-line antimalarial in stock (artemether+lumefantrine, artesunate+amodiaqune) | 99 (88.4) | 58.8 | 526 (96.3) | – |
Paracetamol cap/tab | 104 (92.9) | 100 | 418 (76.2) | 34.6 |
Intermittent preventive treatment of malaria in pregnancy (IPTp) drug (sulfadoxine pyrimethamine) | 62 (55.4) | 28.4 | 356 (65.2) | 17.1 |
ITNs | 29 (25.9) | 73.2 | 185 (33.9) | 26.2 |
Health facility readiness index
Tracers | Category | Frequency, n(%) | Factorial axes* | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |||
Privacy room | No | 31 (27.7) | −0.281a | −1.196 | 0.358 | −2.537 | 1.257 | −1.370 | −0.195 | 0.746 | 0.171 | −5.265 | −3.066 | 1.560 | 0.252 | 1.213 |
Yes | 81 (72.3) | 0.107 | 0.458 | −0.137 | 0.971 | −0.481 | 0.524 | 0.075 | −0.285 | − 0.065 | 2.015 | 1.173 | −0.597 | −0.097 | − 0.464 | |
Emergency transportation | No | 6 (5.4) | 0.063 | −3.332 | −2.716 | 4.195 | 0.012 | −7.946 | 4.844 | −11.193 | −0.109 | − 1.787 | 1.657 | 3.354 | −2.609 | 2.616 |
Yes | 106 (94.6) | −0.004 | 0.189 | 0.154 | −0.237 | −0.001 | 0.450 | −0.274 | 0.634 | 0.006 | 0.101 | −0.094 | −0.190 | 0.148 | −0.148 | |
Light power | No | 20 (17.9) | −0.925 | −3.350b | 0.885 | 0.805 | 0.298 | 2.439 | −4.057 | −1.751 | −0.649 | −3.378 | 2.240 | −4.542 | −0.070 | − 0.001 |
Yes | 92 (82.1) | 0.201 | 0.728 | −0.192 | −0.175 | − 0.065 | −0.530 | 0.882 | 0.381 | 0.141 | 0.734 | −0.487 | 0.987 | 0.015 | 0.000 | |
Safe final disposal of sharps | No | 27 (24.1) | 1.254 | −0.656 | −4.856 | −2.973 | − 0.352 | 0.664 | − 0.421 | − 0.995 | 1.152 | − 0.588 | 2.051 | − 0.445 | − 0.888 | − 0.100 |
Yes | 85 (75.9) | −0.398 | 0.208 | 1.542 | 0.944 | 0.112 | −0.211 | 0.134 | 0.316 | −0.366 | 0.187 | −0.652 | 0.142 | 0.282 | 0.032 | |
Safe final disposal of infectious wastes | No | 30 (26.8) | 0.859 | −0.684 | −4.958 | −2.727 | 0.017 | 0.163 | −1.408 | − 0.591 | 1.160 | 0.798 | −0.069 | 0.185 | −0.102 | − 0.391 |
Yes | 82 (73.2) | −0.314 | 0.250 | 1.814 | 0.998 | −0.006 | −0.060 | 0.515 | 0.216 | −0.424 | −0.292 | 0.025 | −0.068 | 0.037 | 0.143 | |
Appropriate storage of infectious waste | No | 9 (8.0) | 1.198 | −2.643 | 0.035 | 1.036 | −1.691 | −9.057 | − 1.236 | − 0.570 | − 1.376 | 2.107 | 5.636 | −5.990 | 3.825 | 3.190 |
Yes | 103 (92.0) | −0.105 | 0.231 | − 0.003 | − 0.091 | 0.148 | 0.791 | 0.108 | 0.050 | 0.120 | −0.184 | −0.492 | 0.523 | −0.334 | − 0.279 | |
Latex gloves | No | 12 (10.1) | −0.252 | −3.347 | 0.867 | 0.983 | −4.095 | −0.858 | −6.782 | 3.797 | −3.464 | 0.525 | 2.358 | 0.705 | −3.537 | −1.541 |
Yes | 100 (89.9) | 0.030 | 0.402 | −0.104 | − 0.118 | 0.491 | 0.103 | 0.814 | −0.456 | 0.416 | −0.063 | −0.283 | − 0.085 | 0.424 | 0.185 | |
Guidelines for standard precautions | No | 14 (22.5) | −3.610 | 0.980 | −1.949 | −1.532 | − 1.850 | − 1.734 | 4.077 | 1.023 | −2.052 | − 3.909 | − 0.936 | − 3.326 | − 1.546 | 1.195 |
Yes | 98 (87.5) | 0.516 | −0.140 | 0.278 | 0.219 | 0.264 | 0.248 | −0.582 | − 0.146 | 0.293 | 0.558 | 0.134 | 0.475 | 0.221 | −0.171 | |
Haemoglobin test | No | 40 (35.7) | −1.086 | −1.396 | −0.563 | 0.630 | −2.200 | 0.331 | 0.568 | −0.251 | − 2.686 | 1.100 | − 0.855 | 1.830 | −3.237 | 0.473 |
Yes | 72 (64.3) | 0.603 | 0.775 | 0.313 | −0.350 | 1.222 | −0.184 | − 0.316 | 0.139 | 1.492 | −0.611 | 0.475 | −1.017 | 1.798 | −0.263 | |
Glucose dipstick | No | 8 (7.1) | −2.850 | 0.482 | −4.354 | 0.289 | −6.397 | 2.569 | 3.601 | 4.457 | −1.015 | −5.601 | 0.354 | −5.051 | −0.402 | − 0.182 |
Yes | 104 (92.9) | 0.219 | −0.037 | 0.335 | −0.022 | 0.492 | − 0.198 | − 0.277 | − 0.343 | 0.078 | 0.431 | − 0.027 | 0.389 | 0.031 | 0.014 | |
Amlopdipin | No | 87 (77.7) | −0.329 | − 0.723 | 0.354 | − 0.378 | − 0.280 | − 0.416 | − 0.848 | 0.125 | 1.106 | 0.339 | − 0.459 | 0.036 | 0.424 | 0.184 |
Yes | 25 (22.3) | 1.144 | 2.515 | −1.231 | 1.315 | 0.974 | 1.448 | 2.953 | −0.436 | − 3.848 | −1.180 | 1.597 | −0.125 | − 1.477 | −0.640 | |
Aspirin | No | 18 (16.1) | −3.484 | 3.093 | −0.109 | − 0.623 | 1.267 | −1.229 | 0.818 | 2.121 | −2.599 | 1.476 | 0.217 | − 2.705 | 1.985 | 1.667 |
Yes | 94 (83.9) | 0.667 | −0.592 | 0.021 | 0.119 | −0.243 | 0.235 | −0.157 | − 0.406 | 0.498 | − 0.283 | − 0.042 | 0.518 | − 0.380 | − 0.319 | |
Beclomethasone inhaler | No | 98 (87.5) | −0.205 | −0.683 | 0.214 | −0.707 | − 0.065 | − 0.013 | 0.293 | − 0.313 | − 0.362 | 0.313 | 0.484 | 0.025 | 0.342 | −0.079 |
Yes | 14 (12.5) | 1.435 | 4.781 | −1.495 | 4.948 | 0.452 | 0.094 | −2.052 | 2.190 | 2.536 | − 2.189 | −3.386 | −0.177 | − 2.394 | 0.555 | |
Beta-blockers | No | 92 (82.1) | −0.433 | − 0.793 | 0.614 | −0.473 | − 0.185 | 0.294 | 0.561 | − 0.134 | 0.132 | −0.074 | 0.098 | 0.032 | 0.439 | 0.587 |
Yes | 20 (17.9) | 1.990 | 3.648 | −2.824 | 2.176 | 0.849 | −1.355 | −2.581 | 0.616 | −0.609 | 0.339 | − 0.450 | − 0.145 | − 2.021 | − 2.701 | |
Ceftriaxone | No | 9 (8.0) | −6.392 | 1.090 | 0.991 | −0.869 | 3.199 | −1.868 | −2.313 | −2.918 | 2.354 | −0.844 | 3.647 | 1.036 | −6.562 | −1.918 |
Yes | 103 (92.0) | 0.558 | −0.095 | − 0.087 | 0.076 | − 0.280 | 0.163 | 0.202 | 0.255 | −0.206 | 0.074 | −0.319 | − 0.090 | 0.573 | 0.168 | |
Gentamicin | No | 11 (9.8) | −4.331 | −1.279 | −2.234 | 4.478 | 2.838 | 2.256 | −0.629 | − 0.754 | 1.864 | 1.838 | −1.003 | −2.284 | −0.105 | 6.498 |
Yes | 101 (90.2) | 0.472 | 0.139 | 0.243 | −0.488 | − 0.309 | − 0.246 | 0.069 | 0.082 | − 0.203 | − 0.200 | 0.109 | 0.249 | 0.011 | −0.708 | |
Glibenclamide | No | 73 (65.2) | −0.724 | −0.211 | − 0.581 | 0.607 | 0.655 | 0.053 | −0.176 | −0.305 | −1.378 | − 0.786 | 0.346 | 0.540 | 1.845 | −1.922 |
Yes | 39 (34.8) | 1.356 | 0.395 | 1.088 | −1.137 | − 1.225 | − 0.099 | 0.329 | 0.571 | 2.580 | 1.471 | −0.648 | −1.011 | −3.453 | 3.598 | |
Insulin injectable | No | 104 (92.9) | −0.123 | −0.424 | 0.222 | −0.186 | − 0.106 | −0.147 | 0.493 | 0.038 | 0.378 | 0.233 | −0.339 | − 0.364 | − 0.207 | −0.641 |
Yes | 8 (7.1) | 1.596 | 5.512 | −2.880 | 2.420 | 1.375 | 1.909 | −6.404 | −0.489 | −4.911 | −3.035 | 4.404 | 4.737 | 2.688 | 8.330 | |
Magnesium | No | 34 (30.4) | −2.083 | − 2.028 | −0.340 | 1.431 | 0.424 | 0.597 | −1.968 | 0.063 | 0.339 | −0.313 | −2.323 | 0.905 | 0.300 | −0.988 |
Yes | 78 (69.6) | 0.908 | 0.884 | 0.148 | −0.624 | − 0.185 | − 0.260 | 0.858 | −0.028 | − 0.148 | 0.136 | 1.013 | −0.395 | − 0.131 | 0.431 | |
Oxytocin | No | 14 (12.5) | −3.089 | −0.951 | −3.370 | 5.102 | −0.779 | 2.837 | 1.260 | −2.386 | 2.970 | 1.110 | −1.926 | − 2.982 | 0.951 | −0.272 |
Yes | 98 (87.5) | 0.441 | 0.136 | 0.481 | −0.729 | 0.111 | −0.405 | − 0.180 | 0.341 | − 0.424 | − 0.159 | 0.275 | 0.426 | − 0.136 | 0.039 | |
Salbutamol | No | 26 (23.2) | −3.000 | − 0.517 | −1.091 | −1.330 | −0.915 | − 0.662 | − 0.223 | 1.480 | −2.038 | 1.850 | − 0.362 | 1.727 | 0.879 | 1.003 |
Yes | 86 (76.8) | 0.907 | 0.156 | 0.330 | 0.402 | 0.277 | 0.200 | 0.067 | −0.448 | 0.616 | − 0.559 | 0.109 | − 0.522 | − 0.266 | − 0.303 | |
Zinc | No | 35 (31.3) | −2.157 | 0.502 | −0.495 | −0.975 | 0.011 | 2.273 | 0.503 | −0.816 | 1.147 | 0.610 | 1.572 | 2.790 | 1.487 | 0.844 |
Yes | 77 (68.8) | 0.980 | −0.228 | 0.225 | 0.443 | −0.005 | −1.033 | − 0.229 | 0.371 | −0.522 | − 0.277 | − 0.715 | − 1.268 | − 0.676 | − 0.383 | |
ITNs | No | 83 (74.1) | −0.220 | 0.045 | −0.747 | − 0.247 | 0.762 | −1.081 | −0.434 | − 0.005 | − 0.520 | 0.795 | − 1.332 | − 0.377 | 0.161 | − 0.081 |
Yes | 29 (25.9) | 0.628 | −0.128 | 2.139 | 0.708 | −2.180 | 3.093 | 1.242 | 0.015 | 1.487 | −2.276 | 3.811 | 1.079 | −0.461 | 0.231 | |
Staff trained in malaria diagnosis and treatment | No | 33 (29.5) | −1.091 | 1.604 | −0.341 | − 0.226 | −3.506 | − 0.728 | − 1.149 | 1.928 | 2.217 | − 0.102 | 0.246 | 0.246 | 1.343 | −0.185 |
Yes | 79 (70 5) | 0.456 | −0.670 | 0.143 | 0.094 | 1.465 | 0.304 | 0.480 | − 0.806 | −0.926 | 0.043 | − 0.103 | − 0.103 | − 0.561 | 0.077 | |
Staff trained in intermittent preventive treatment in pregnancy (IPTp) | No | 38 (33.9) | −0.158 | −0.459 | − 0.829 | 2.575 | −1.426 | −2.856 | 0.619 | 0.713 | 1.757 | −1.492 | 1.060 | 2.415 | 0.922 | 0.162 |
Yes | 74 (66.1) | 0.081 | 0.236 | 0.426 | −1.322 | 0.732 | 1.467 | −0.318 | −0.366 | − 0.902 | 0.766 | − 0.544 | −1.240 | − 0.474 | − 0.083 | |
First line treatment of malaria | No | 13 (11.6) | −4.606 | 2.906 | 0.766 | −1.353 | 0.142 | −1.435 | 0.786 | 0.550 | 2.369 | 1.904 | 2.504 | 0.379 | −0.856 | −4.781 |
Yes | 99 (88.4) | 0.605 | −0.382 | − 0.101 | 0.178 | − 0.019 | 0.188 | − 0.103 | − 0.072 | −0.311 | − 0.250 | −0.329 | − 0.050 | 0.112 | 0.628 | |
IPTp drug | No | 50 (44.6) | −5.589 | 3.721 | 1.822 | −2.447 | 5.322 | −2.872 | − 2.985 | 0.352 | 1.426 | −2.683 | 3.527 | −0.455 | −4.909 | 2.079 |
Yes | 62 (55.4) | 0.430 | −0.286 | − 0.140 | 0.188 | − 0.409 | 0.221 | 0.230 | −0.027 | − 0.110 | 0.206 | −0.271 | 0.035 | 0.378 | −0.160 | |
Carbamazepine | No | 84 (75.0) | −0.144 | 0.764 | 0.367 | −0.450 | −1.050 | 0.110 | −0.594 | −1.146 | −0.364 | 0.136 | −0.686 | 0.030 | 0.566 | 0.637 |
Yes | 28 (25.0) | 0.432 | −2.292 | −1.101 | 1.349 | 3.149 | −0.331 | 1.782 | 3.438 | 1.093 | −0.408 | 2.057 | −0.091 | −1.698 | −1.911 | |
Haloperidol | No | 85 (75.9) | −0.183 | 0.825 | 0.330 | −0.199 | − 0.894 | − 0.172 | − 0.410 | −1.475 | − 0.025 | −0.361 | − 0.402 | − 0.354 | − 0.078 | − 0.660 |
Yes | 27 (24.1) | 0.577 | −2.599 | −1.039 | 0.627 | 2.815 | 0.541 | 1.292 | 4.644 | 0.079 | 1.136 | 1.266 | 1.116 | 0.244 | 2.078 | |
Inertia explained by the factorial axis (%) | 14.5 | 8.9 | 6.7 | 6.1 | 5.9 | 5.3 | 4.7 | 4.4 | 4.0 | 3.7 | 3.6 | 3.4 | 3.0 | 2.9 |
Tracers | Category | Frequency | Factorial axes* | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |||
Improved water source | No | 0.457a | 0.048 | −5.424 | 0.301 | −5.699 | 0.095 | |
Yes | 476 (87.2) | −0.067 | −0.007 | 0.798 | −0.044 | 0.838 | − 0.014 | |
Emergency transportation | No | −5.770b | −0.594 | −1.284 | −0.830 | −1.483 | 3.543 | |
Yes | 515 (94.3) | 0.347 | 0.036 | 0.077 | 0.050 | 0.089 | −0.213 | |
Soap or running water | No | −1.239 | −0.895 | 8.502 | −5.784 | −7.725 | −0.620 | |
Yes | 518 (94.9) | 0.067 | 0.048 | −0.460 | 0.313 | 0.418 | 0.034 | |
Storage infectious waste | No | 0.602 | −6.612 | − 0.633 | 1.732 | −0.529 | 0.274 | |
Yes | 494 (90.5) | −0.063 | 0.696 | 0.067 | −0.182 | 0.056 | −0.029 | |
Latex gloves | No | 0.418 | −7.016 | 1.337 | 1.780 | −0.218 | 0.025 | |
Yes | 499 (91.4) | −0.039 | 0.661 | −0.126 | − 0.168 | 0.021 | − 0.002 | |
Urine dipstick | No | −4.999 | 0.574 | −0.718 | 1.596 | −1.019 | 2.063 | |
yesYes | 501 (91.8) | 0.449 | −0.052 | 0.065 | −0.143 | 0.092 | −0.185 | |
Ceftriaxone | No | −3.772 | −1.310 | − 1.489 | − 1.567 | 3.602 | 1.638 | |
Yes | 492 (90.1) | 0.414 | 0.144 | 0.163 | 0.172 | −0.395 | − 0.180 | |
Oxytocin | No | −5.750 | −0.119 | 1.406 | 0.905 | −0.920 | 0.604 | |
Yes | 502 (91.9) | 0.504 | 0.010 | −0.123 | − 0.079 | 0.081 | − 0.053 | |
Thiazidic | No | 0.048 | −0.190 | −0.263 | − 0.751 | 0.136 | 0.041 | |
Yes | 41 (7.5) | −0.586 | 2.338 | 3.235 | 9.250 | −1.672 | −0.510 | |
IPTg training | No | − 1.518 | −0.266 | − 0.552 | − 0.122 | 0.163 | −4.223 | |
Yes | 370 (67.8) | 0.722 | 0.127 | 0.263 | 0.058 | −0.077 | 2.009 | |
Inertia explained by the factorial axis (%) | 20.0 | 14.2 | 10.5 | 10.3 | 9.9 | 8.8 |
Association between health facility readiness and malaria mortality
Medical centres | Peripheral health centres | |
---|---|---|
Readiness index | MRRa (95% BCI) | MRR (95% BCI) |
Low | 1.00 | 1.00 |
Middle | 0.94 (0.76–1.25) | 0.74 (0.54–1.00) |
High | 0.81 (0.74–2.51) | 0.41 (0.19–0.91)* |
Location | ||
Rural | 1.00 | 1.00 |
Urban | 0.97 (0.48–1.77) | 0.49 (0.31–0.78)* |
Administrative status | ||
Private | 1.00 | 1.00 |
Public | 1.12 (0.51–2.17) | 0.69 (0.46–1.01) |
Spatial parameters | ||
Spatial variance | 0.26 (0.14–0.53) | 0.46 (0.29–0.67) |
Spatial range (km) | 43.3 (13.6–89.9) | 26.32 (6.39–83.1) |